Remove 2022 Remove Computational Chemistry Remove Drugs
article thumbnail

Patent Highlights: Allosteric AR Modulators, Glycogen Synthase Inhibitors, and More

Drug Hunter

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples. log in: Username or E-mail Password Remember Me Forgot Password The post Patent Highlights: Allosteric AR Modulators, Glycogen Synthase Inhibitors, and More appeared first on Drug Hunter.

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

“AI will not replace drug discovery scientists, but drug discovery scientists who use AI will replace those who don’t” – comment during EFMC meeting 2018 Progressing a drug molecule from concept to commercialisation typically takes 10-15 years and has high associated costs of up to $2 billion per launched drug, if all failures are factored in.

Drugs 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. Previous acquisitions made were Peak Proteins in April 2022 and SB Drug Discovery in January 2023.

article thumbnail

Five days in Vermont

Molecular Design

The five days spent discussing computer-aided drug design (CADD) in Vermont are what I’ll be covering in this post and I think it’s worth saying something about what drugs need to do in order to function safely. It is indeed a small world.

article thumbnail

The Book of Nimbus

LifeSciVC

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.